Matches in Wikidata for { <http://www.wikidata.org/entity/Q45815733> ?p ?o ?g. }
- Q45815733 description "2013 nî lūn-bûn" @default.
- Q45815733 description "2013年の論文" @default.
- Q45815733 description "2013年学术文章" @default.
- Q45815733 description "2013年学术文章" @default.
- Q45815733 description "2013年学术文章" @default.
- Q45815733 description "2013年学术文章" @default.
- Q45815733 description "2013年学术文章" @default.
- Q45815733 description "2013年学术文章" @default.
- Q45815733 description "2013年學術文章" @default.
- Q45815733 description "2013年學術文章" @default.
- Q45815733 description "2013年學術文章" @default.
- Q45815733 description "2013年學術文章" @default.
- Q45815733 description "2013年學術文章" @default.
- Q45815733 description "2013년 논문" @default.
- Q45815733 description "article científic" @default.
- Q45815733 description "article scientific" @default.
- Q45815733 description "article scientifique" @default.
- Q45815733 description "articol științific" @default.
- Q45815733 description "articolo scientifico" @default.
- Q45815733 description "artigo científico" @default.
- Q45815733 description "artigo científico" @default.
- Q45815733 description "artigo científico" @default.
- Q45815733 description "artikel ilmiah" @default.
- Q45815733 description "artikull shkencor" @default.
- Q45815733 description "artikulong pang-agham" @default.
- Q45815733 description "artykuł naukowy" @default.
- Q45815733 description "artículo científico publicado en 2013" @default.
- Q45815733 description "artículu científicu" @default.
- Q45815733 description "bilimsel makale" @default.
- Q45815733 description "bài báo khoa học" @default.
- Q45815733 description "naučni članak" @default.
- Q45815733 description "scienca artikolo" @default.
- Q45815733 description "scientific article published on 28 May 2013" @default.
- Q45815733 description "scientific article published on 28 May 2013" @default.
- Q45815733 description "scientific article published on 28 May 2013" @default.
- Q45815733 description "teaduslik artikkel" @default.
- Q45815733 description "tieteellinen artikkeli" @default.
- Q45815733 description "tudományos cikk" @default.
- Q45815733 description "vedecký článok" @default.
- Q45815733 description "vetenskaplig artikel" @default.
- Q45815733 description "videnskabelig artikel" @default.
- Q45815733 description "vitenskapelig artikkel" @default.
- Q45815733 description "vitskapeleg artikkel" @default.
- Q45815733 description "vědecký článek" @default.
- Q45815733 description "wetenschappelijk artikel" @default.
- Q45815733 description "wissenschaftlicher Artikel" @default.
- Q45815733 description "επιστημονικό άρθρο" @default.
- Q45815733 description "мақолаи илмӣ" @default.
- Q45815733 description "наукова стаття, опублікована в травні 2013" @default.
- Q45815733 description "научна статия" @default.
- Q45815733 description "научная статья" @default.
- Q45815733 description "научни чланак" @default.
- Q45815733 description "научни чланак" @default.
- Q45815733 description "מאמר מדעי" @default.
- Q45815733 description "مقالة علمية نشرت في 28 مايو 2013" @default.
- Q45815733 description "২৮ মে ২০১৩-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q45815733 description "บทความทางวิทยาศาสตร์" @default.
- Q45815733 description "სამეცნიერო სტატია" @default.
- Q45815733 name "Dasatinib in children and adolescents with relapsed or refractory leukemia: results of the CA180-018 phase I dose-escalation study of the Innovative Therapies for Children with Cancer Consortium" @default.
- Q45815733 name "Dasatinib in children and adolescents with relapsed or refractory leukemia: results of the CA180-018 phase I dose-escalation study of the Innovative Therapies for Children with Cancer Consortium" @default.
- Q45815733 type Item @default.
- Q45815733 label "Dasatinib in children and adolescents with relapsed or refractory leukemia: results of the CA180-018 phase I dose-escalation study of the Innovative Therapies for Children with Cancer Consortium" @default.
- Q45815733 label "Dasatinib in children and adolescents with relapsed or refractory leukemia: results of the CA180-018 phase I dose-escalation study of the Innovative Therapies for Children with Cancer Consortium" @default.
- Q45815733 prefLabel "Dasatinib in children and adolescents with relapsed or refractory leukemia: results of the CA180-018 phase I dose-escalation study of the Innovative Therapies for Children with Cancer Consortium" @default.
- Q45815733 prefLabel "Dasatinib in children and adolescents with relapsed or refractory leukemia: results of the CA180-018 phase I dose-escalation study of the Innovative Therapies for Children with Cancer Consortium" @default.
- Q45815733 P1433 Q45815733-A3E4F29B-0639-44A0-A95D-A37F5E057128 @default.
- Q45815733 P1476 Q45815733-CB324C76-A861-4392-8EF5-FE1A420AEE47 @default.
- Q45815733 P2093 Q45815733-0016CE6E-6E36-40D6-875D-1B15352C21BB @default.
- Q45815733 P2093 Q45815733-156C831A-41D9-4E6B-A883-E693F4DAA530 @default.
- Q45815733 P2093 Q45815733-1CC59E48-8046-43DE-A363-3223C53B5304 @default.
- Q45815733 P2093 Q45815733-259984C2-2E6D-485E-B886-72BA7305B267 @default.
- Q45815733 P2093 Q45815733-35A67B2E-F0E7-406C-AEC0-3398D3880FDF @default.
- Q45815733 P2093 Q45815733-6B9FC33B-65BB-4FC9-AF93-CE3DB8F055B6 @default.
- Q45815733 P2093 Q45815733-7ECEC715-B3A8-4080-9CBA-BC699D052E47 @default.
- Q45815733 P2093 Q45815733-8089C45A-0BFC-45F0-8D2B-80FD08387C59 @default.
- Q45815733 P2093 Q45815733-82DBFF33-6136-409D-8AA9-8C5946A6BA22 @default.
- Q45815733 P2093 Q45815733-C7B806A8-28F7-4831-B6D3-BD3A75D27B23 @default.
- Q45815733 P2093 Q45815733-D8658411-0420-4106-ADB7-FB7E7351DF95 @default.
- Q45815733 P2093 Q45815733-E420D029-071C-41C4-BC7E-E02AF21F3761 @default.
- Q45815733 P2093 Q45815733-E52FAEB6-8398-4EF7-90E5-F532B4F1F1A3 @default.
- Q45815733 P2093 Q45815733-E94DDC3E-A131-40F6-88D0-0BEB61F4B54D @default.
- Q45815733 P304 Q45815733-5ABD1D70-3F21-4CBE-84B6-3B3697FCE4BE @default.
- Q45815733 P31 Q45815733-8F700A7C-C937-480A-9CB9-377E11BB2DB0 @default.
- Q45815733 P356 Q45815733-A7AA3CA1-9ADF-465F-9659-28F5B366963D @default.
- Q45815733 P407 Q45815733-18A82948-D187-423B-A960-E69F2E3BF323 @default.
- Q45815733 P433 Q45815733-4A565DB1-69AE-417D-9CAF-AC5F99A40B44 @default.
- Q45815733 P478 Q45815733-25E0EF60-4A14-4DE5-821D-574D13D7D861 @default.
- Q45815733 P50 Q45815733-1EC65D58-AF34-4948-8B32-3DA00DB05D60 @default.
- Q45815733 P50 Q45815733-AD8F49C4-F4DE-4E21-B850-E2DD447403B1 @default.
- Q45815733 P50 Q45815733-D1D01A65-EDB9-42BD-9BE7-3F2711C405C9 @default.
- Q45815733 P577 Q45815733-1D005FF7-8F07-479F-B9AA-24B6AB8A7F5C @default.
- Q45815733 P698 Q45815733-17D1652C-80B9-42E5-B767-7561A4C6B37A @default.
- Q45815733 P921 Q45815733-21A6D775-3E3F-4BBB-B3B0-9C81F5E87C2B @default.
- Q45815733 P921 Q45815733-CC36D8F2-D512-4BBC-98E8-97CEF78A01E2 @default.
- Q45815733 P921 Q45815733-D579F665-2F9A-42D4-AFD0-9C994AD06370 @default.
- Q45815733 P356 JCO.2012.46.8280 @default.
- Q45815733 P698 23715577 @default.
- Q45815733 P1433 Q400292 @default.
- Q45815733 P1476 "Dasatinib in children and adolescents with relapsed or refractory leukemia: results of the CA180-018 phase I dose-escalation study of the Innovative Therapies for Children with Cancer Consortium" @default.
- Q45815733 P2093 "André Baruchel" @default.